Stephen Davies

Stephen John Davies was the founder of Summit Therapeutics Ltd. founded in 2003, where the title held was Independent Non-Executive Director from 2013 to 2018.
Dr. Davies is the founder of Syniad Innovations founded in 2015, holding the title of President since 2015.
Dr. Davies is the founder of Gemina Laboratories Ltd. founded in 2017, holding the title of Non-Executive Chairman since 2022.
Dr. Davies is also the founder of Oxray Ltd.,MuOx Ltd.,Scientific Research Capital Ltd.,Oxstem Ltd...
Dr. Davies is currently Director at Sci-Ink Ltd. Dr. Davies is currently Director at Ecomine Technologies Corp.
since 2017.
Dr. Davies is currently Professor at the University of Oxford since 1996.
Dr. Davies is currently President at Physical Science Innovations Corp.
since 2015.
Former positions include Non-Executive Director at Oxeco Plc from 2007 to 2009.
Director at SRC Holdings Corp.
CFO, Chief Operating Officer & Director at IP Group Plc from 2001 to 2005.
Chief Financial Officer & Finance Director at IndexIT Partnership.
Associate Director at Beeson Gregory Ltd. Non-Executive Director at Oxford University Innovation Ltd. Education includes undergraduate, graduate, and doctorate degrees from the University of Oxford.
Graduate degree from McGill University.
Doctorate degree from Université de Paris IV Paris-Sorbonne.